SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cempra Pharmaceuticals, Inc. Continues to Differentiate Solithromycin's Potency and Activity Compared to Other Macrolides in Presentations at IDWeek 2012™